Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in United States (Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +3 more
Jan 27, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +38 more
Jan 25, 2023

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
Has Results
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Birmingham, Alabama
  • +229 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Huntsville, Alabama
  • +226 more
Apr 19, 2021

Carcinoma, Renal Cell Trial in United Kingdom, United States (Pazopanib, MK-3475)

Completed
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +5 more
Feb 28, 2020

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib)

Completed
  • Carcinoma, Renal Cell
  • Duarte, California
  • +18 more
Mar 4, 2019

Carcinoma, Renal Cell Trial in United States (foretinib (formerly GSK1363089 or XL880))

Completed
Has Results
  • Carcinoma, Renal Cell
  • foretinib (formerly GSK1363089 or XL880)
  • Greenbrae, California
  • +11 more
Nov 8, 2017

Carcinoma, Renal Cell Trial in Minneapolis, Nashville (GW786034, oral, GW786034, IV, GW786034, radiolabeled oral)

Completed
  • Carcinoma, Renal Cell
  • GW786034, oral
  • +2 more
  • Minneapolis, Minnesota
  • +1 more
Nov 13, 2017

Carcinoma, Renal Cell Trial in United States (Pazopanib, Placebo for pazopanib, Moxifloxacin)

Completed
  • Carcinoma, Renal Cell
  • Duarte, California
  • +7 more
Nov 10, 2017

Carcinoma, Renal Cell Trial in Worldwide (GW786034, Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Duarte, California
  • +44 more
Feb 23, 2017

Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)

Completed
  • Carcinoma, Renal Cell
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +8 more
Dec 17, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Interferon Alfa
  • +2 more
  • Little Rock, Arkansas
  • +153 more
Sep 24, 2012

Carcinoma, Renal Cell, Kidney Tumors Trial in United States (ZD6126, Placebo)

Suspended
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Los Angeles, California
  • +15 more
Jan 25, 2011

Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Jonesboro, Arkansas
  • +123 more
Jan 19, 2010

Carcinoma, Renal Cell Trial in United States (Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jan 6, 2010